Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Syncona (SYNC) Share Price

Price 111.20p on 08-09-2026 at 14:56:27
Change -1.80p -1.59%
Buy 111.60p
Sell 111.20p
Last Trade: Sell 4,995.00 at 111.297p
Day's Volume: 224,130
Last Close: 113.00p
Open: 112.40p
ISIN: GG00B8P59C08
Day's Range 111.20p - 112.40p
52wk Range: 86.90p - 117.00p
Market Capitalisation: £676.32m
VWAP: 111.8539p
Shares in Issue: 608.20m

Syncona (SYNC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 4,995 111.297p Ordinary
15:56:26 - 08-Sep-26
Sell* 300 111.20p Automatic Execution
15:40:52 - 08-Sep-26
Sell* 396 111.20p Automatic Execution
15:40:51 - 08-Sep-26
Sell* 20 111.20p Automatic Execution
15:35:30 - 08-Sep-26
Sell* 20 111.20p Automatic Execution
15:33:53 - 08-Sep-26
Sell* 20 111.20p Automatic Execution
15:32:01 - 08-Sep-26
Sell* 15,000 111.2201p Ordinary
15:31:08 - 08-Sep-26
Buy* 35,000 111.496p SI Trade
15:30:17 - 08-Sep-26
Sell* 3,228 111.3032p Ordinary
15:29:51 - 08-Sep-26
Sell* 5,000 111.297p Ordinary
15:16:13 - 08-Sep-26
See more Syncona trades

Syncona (SYNC) Share Price History

Time period:
to
Date Open High Low Close Volume
7th Sep 2026 (Mon) 114.80 114.80 112.40 113.00 335,271
4th Sep 2026 (Fri) 113.40 113.60 112.00 112.80 301,548
3rd Sep 2026 (Thu) 113.40 113.40 112.80 112.80 480,629
2nd Sep 2026 (Wed) 116.00 116.00 113.20 113.20 375,690
1st Sep 2026 (Tue) 117.00 117.00 113.40 113.40 427,425
31st Aug 2026 (Mon) 114.60 114.60 114.60 114.60 0
28th Aug 2026 (Fri) 116.00 117.00 114.60 114.60 981,236
27th Aug 2026 (Thu) 113.00 115.80 112.00 115.80 352,446
26th Aug 2026 (Wed) 112.00 113.00 110.80 113.00 301,867
25th Aug 2026 (Tue) 109.00 112.00 109.00 112.00 185,554
24th Aug 2026 (Mon) 110.00 111.40 109.00 111.40 313,071
21st Aug 2026 (Fri) 109.40 109.40 108.20 109.40 256,447
20th Aug 2026 (Thu) 108.40 108.40 108.40 108.40 64,791
19th Aug 2026 (Wed) 107.20 109.00 106.00 109.00 2,304,114
18th Aug 2026 (Tue) 107.20 107.60 106.60 106.80 708,981
17th Aug 2026 (Mon) 108.00 108.00 107.00 107.00 218,013
14th Aug 2026 (Fri) 107.60 108.00 107.20 107.40 237,855
13th Aug 2026 (Thu) 107.00 108.00 107.00 107.00 37,289
12th Aug 2026 (Wed) 108.00 108.00 107.00 107.80 571,589
11th Aug 2026 (Tue) 107.80 108.00 107.00 107.00 190,551
10th Aug 2026 (Mon) 109.40 109.40 107.00 107.80 984,169
See more Syncona price history

Syncona (SYNC) Regulatory News

Date Source Headline
25th Aug 2026 5:15 pm RNS Holding(s) in Company
21st Aug 2026 8:00 am RNS Holding(s) in Company
18th Aug 2026 11:05 am RNS Result of AGM
6th Aug 2026 7:00 am RNS First Quarter Update
4th Aug 2026 2:00 pm RNS Holding(s) in Company
3rd Aug 2026 7:00 am RNS Total Voting Rights
30th Jul 2026 2:00 pm RNS Holding(s) in Company
23rd Jul 2026 9:49 am RNS Issue of Shares pursuant to Incentive Scheme
3rd Jul 2026 7:00 am RNS Notice of AGM
3rd Jul 2026 7:00 am RNS Holding(s) in Company
See more Syncona regulatory news

Syncona (SYNC) Share News

WINNERS & LOSERS: Vistry surges on UK government funding boost

25th Aug 2026 10:19

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

UK shareholder meetings calendar - next 7 days

11th Aug 2026 13:48

Read More

FTSE 250 EARNINGS & UPDATES: TBC Bank profits from Georgian economy

6th Aug 2026 14:28

(Alliance News) - The following is a round-up of earnings and trading updates by FTSE 250-listed London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Syncona asset value holds steady amid divergent investment returns

18th Jun 2026 10:43

(Alliance News) - Syncona Ltd on Thursday reported a flat annual performance for net asset value, with upside from Beacon Therapeutics PLC offset by write-downs elsewhere. Read More

IN BRIEF: Syncona invests GBP18 million in Beacon financing round

8th Jan 2026 15:45

Syncona Ltd - London-based investor in life science companies - Invests USD24.5 million in ophthalmic gene therapy company Beacon Therapeutics' USD75 million Series C financing. Says the financing round was oversubscribed and brings Beacon's total funding raised so far to approximately USD367 million. Beacon will use the proceeds "to progress commercialisation plans" and to complete the development of its lead programme laru-zova, "a potential best-in-class gene therapy" for X-linked retinitis pigmentosa, Syncona says. Syncona's holding value of Beacon will now be USD237.6 million, including new capital invested, and it will hold a 38.4% ownership stake. Read More

See more Syncona news
FTSE 100 Latest
Value10,823.76
Change1.63

Login to your account

Forgot Password?

Not Registered